Phase 1 Trial of KH801

Clinical trial NCT06364501 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06364501
Sponsor: Beijing Kanghong Biopharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-09-01
Primary completion: 2026-05-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.